𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prospective validation of the short form liver disease quality of life instrument

✍ Scribed by F. KANWAL; B. M. R. SPIEGEL; R. D. HAYS; F. DURAZO; S. B. HAN; S. SAAB; R. BOLUS; S. J. KIM; I. M. GRALNEK

Book ID
108605443
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
165 KB
Volume
28
Category
Article
ISSN
0269-2813

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Development and validation of Cedars-Sin
Development and validation of Cedars-Sinai Health-Related Quality of Life in Rheumatoid Arthritis (CSHQ-RA) short form instrument
✍ Chiou, Chiun-Fang ;Sherbourne, Cathy D. ;Ofman, Joshua ;Lee, Martin ;Lubeck, Deb 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB 👁 2 views

## Abstract ## Objective To develop an abridged version of the 33‐item Cedars‐Sinai Health‐Related Quality of Life in Rheumatoid Arthritis instrument (CSHQ‐RA) and test the validity and reliability of the abridged instrument. ## Methods Items from the original 33‐item, 5‐domain CSHQ‐RA were asse

Validation of a disease-specific quality
Validation of a disease-specific quality-of-life instrument for acoustic neuroma : The Penn Acoustic Neuroma Quality-of-Life Scale
✍ Brian T. Shaffer; Michael S. Cohen; Douglas C. Bigelow; Michael J. Ruckenstein 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 467 KB

## Abstract ## Objectives/Hypothesis: To design and validate the first disease‐specific quality‐of‐life instrument for acoustic neuroma, the Penn Acoustic Neuroma Quality‐of‐Life (PANQOL) scale. ## Study Design: Prospective instrument validation. ## Methods: One hundred forty‐three patients wi

Development and validation of a disease-
Development and validation of a disease-targeted quality of life instrument in chronic hepatitis B: The hepatitis B quality of life instrument, version 1.0
✍ Brennan M. R. Spiegel; Roger Bolus; Steven Han; Myron Tong; Eric Esrailian; Jenn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

Despite the increasing realization that health-related quality of life (HRQOL) is an important outcome in chronic HBV infection, there are no validated, disease-targeted instruments currently available. We sought to develop and validate the first disease-targeted HRQOL instrument in noncirrhotic HBV